|
|
|
|
|
by ulfw
1111 days ago
|
|
Can someone explain the numbers to me? "After five years, 88% of patients who took the daily pill after the removal of their tumour were still alive, compared with 78% of patients treated with a placebo. Overall, there was a 51% lower risk of death for those who received osimertinib compared with those who received placebo." So 88% instead of 78% without the pill were still alive five years on. I assume that is the maximum range they could test. How was the 51% then calculated? Edit: thank you all for the explanation. That makes a lot of sense! |
|
The true value could easily be 51% if the percentages reported in the Guardian were rounded.